Study Highlights Role of TB Risk Scoring Tool in DiagnosisResearchers have developed a TB risk scoring tool by reviewing past patient data ...

This was likely triggered by management's sharing positive data from a Phase 2b study of MM-120 in patients with generalized anxiety disorder (“GAD ... to $99.7 million as of December ...

Lexapro is an antidepressant medication commonly prescribed for anxiety. Here's how to know the best time of day to take it.

The company's lead compound, MM120, has shown promising results in a Phase 2b trial for Generalized Anxiety Disorder (GAD), and the company is gearing up for Phase 3 trials for both GAD and Major ...

Virtual reality meditation effectively reduces depression and anxiety symptoms while improving emotional regulation in ...

Beta-blockers (also referred to as β-blockers) are a type of medication commonly used to manage heart-related health conditions like chest pain and high blood pressure. However, there's also another ...

Methods: IA and anxiety symptoms were assessed using the Internet Addiction Test (IAT) and the Generalized Anxiety Disorder Screener (GAD-7), respectively. The structure of IA and anxiety symptoms was ...

Panic disorder (PD), generalized anxiety disorder (GAD), and social anxiety disorder (SAD ... are also approved for treatment either as monotherapy or adjunctive treatment for anxiety (4–7). Despite ...

Shares in Mind Medicine (MNMD) are surging, following a shift in market sentiment regarding possible growth and the potential ...

Pre- and post-intervention assessments were undertaken using participant self-report measures: Generalised Anxiety Disorder (GAD-7) and Patient Health Questionnaire (PHQ-9). Results: Reliable ...

After treatment with CBD, 79% of the participants experienced decreased anxiety levels, and 66.7% saw improved sleep ... CBD could help reduce anxiety in GAD and seasonal affective disorder.